US 11957680
Pyruvate kinase activators for use in treating blood disorders
granted A61KA61K31/5025A61K31/506
Quick answer
US patent 11957680 (Pyruvate kinase activators for use in treating blood disorders) held by Agios Pharmaceuticals, Inc. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/5025, A61K31/506, A61K31/519, A61K45/06